Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
193,539,047
-
Number of holders
-
475
-
Total 13F shares, excl. options
-
178,407,022
-
Shares change
-
-900,195
-
Total reported value, excl. options
-
$15,847,079,543
-
Value change
-
-$79,141,968
-
Put/Call ratio
-
147%
-
Number of buys
-
248
-
Number of sells
-
-186
-
Price
-
$88.83
Significant Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q1 2019
557 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share as of Q1 2019.
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) has 475 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 178,407,022 shares
of 193,539,047 outstanding shares and own 92% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (17,749,061 shares), VANGUARD GROUP INC (15,709,874 shares), PRIMECAP MANAGEMENT CO/CA/ (14,190,873 shares), BlackRock Inc. (12,663,369 shares), JENNISON ASSOCIATES LLC (12,412,593 shares), BAKER BROS. ADVISORS LP (7,589,294 shares), SANDS CAPITAL MANAGEMENT, LLC (5,881,446 shares), Viking Global Investors LP (5,128,909 shares), Clearbridge Investments, LLC (5,005,318 shares), and STATE STREET CORP (4,636,152 shares).
This table shows the top 475 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.